Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

Amcor enters its transition period with improving operating momentum: fourth-quarter comparable volumes grew approximately 0.5%, adjusted diluted EPS increased to USD 1.23, and fiscal-2026 free cash flow reached USD 1.303 billion. The Berry combination offers a material earnings catalyst through a stated USD 650 million synergy opportunity, but execution risk remains meaningful because fiscal-2026 organic sales declined, net debt was USD 12.897 billion, integration work continues and management is still reviewing non-core assets. At the issuer-displayed NYSE price of USD 46.67, the risk/reward supports a Hold pending evidence that positive volume growth, additional synergy capture and deleveraging persist together.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets12 analysts · as of 18 Aug 2026
Low · most bearish analyst$42.00
Mean target$50.18
High · most bullish analyst$60.00
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 2 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$35.0017%

Volumes turn negative, integration savings fail to offset weak price and mix, or cash conversion disappoints, leaving leverage above management's outlook. A slower synergy ramp or disruptive portfolio actions would reduce confidence in the post-Berry earnings and capital-return proposition.

Base CaseCentral scenario
$50.1858%
Matches the consensus mean

Amcor delivers transition-period adjusted EPS within USD 1.80-1.90, reaches leverage of approximately 3.5x-3.6x and continues capturing Berry synergies, while modest volume growth and input-cost volatility limit multiple expansion.

Bull CaseUpside scenario
$60.0025%

Synergies continue ahead of the original integration trajectory, underlying volumes remain positive, portfolio optimization improves business quality and cash generation supports faster deleveraging. Successful execution toward the USD 650 million synergy objective could sustain double-digit earnings momentum and justify a higher equity value.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • The Berry combination substantially broadened Amcor's packaging portfolio and created a stated USD 650 million total pre-tax synergy opportunity by the end of fiscal 2028.
  • Fourth-quarter fiscal-2026 execution improved, with approximately 0.5% comparable combined volume growth and adjusted diluted EPS growth of 23%.
  • Fiscal-2026 free cash flow reached USD 1.303 billion despite approximately USD 290 million of transaction, restructuring and integration costs.
Sign in / Sign up to read more
Key Investment Risks
  • Fiscal-2026 organic sales declined 2%, showing that acquisition-driven reported growth did not eliminate underlying demand and mix pressure.
  • Net debt remained USD 12.897 billion at June 30, 2026, making cash conversion and delivery of the 3.5x-3.6x leverage outlook important.
  • The Berry integration and portfolio review create execution, restructuring, customer-retention and divestiture risks.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.